help button home button Am J Pathol Epitomics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

A more recent version of this article appeared on July 1, 2007

Published online before print May 24, 2007
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
ajpath.2007.060896v1
171/1/361    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dietrich, T.
Right arrow Articles by Cursiefen, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dietrich, T.
Right arrow Articles by Cursiefen, C.
Copyright © 2007 American Society for Investigative Pathology
American Journal of Pathology, doi:10.2353/ajpath.2007.060896


Accepted for publication March 28, 2007.


Article

Inhibition of Inflammatory Lymphangiogenesis by Integrin {alpha}5 Blockade

Tina Dietrich*@, Jasmine Onderka*, Felix Bock*, Friedrich E. Kruse*, Dörte Vossmeyer{dagger}, Roland Stragies{dagger}, Grit Zahn{dagger}, and Claus Cursiefen*

From the Department of Ophthalmology,* University of Erlangen-Nürnberg, Erlangen; and Jerini AG,{dagger} Berlin, Germany

@ To whom correspondence should be addressed. E-mail: tinadie{at}gmx.net.


   Abstract

The interaction between endothelial cells and extracellular matrix proteins plays an important role in (hem)angiogenesis. Integrins are able to mediate the outgrowth of newly formed blood vessels. In contrast, the role of integrins in lymphangiogenesis, ie, the outgrowth of new from pre-existing lymphatic vessels, has so far been unclear. Here, expression and functional relevance of integrins on lymphatic endothelium in vivo was investigated using the mouse model of combined inflammatory corneal hemangiogenesis and lymphangiogenesis. Immunohistochemistry revealed novel expression of both integrin {alpha}5 and {alpha}v on both resting and activated lymphatic vessels in vivo. Integrin {alpha}5-inhibiting small molecules significantly blocked the outgrowth of new lymphatic vessels into the cornea in a dose-dependent manner. The outgrowth of blood vessels was less significantly affected by this treatment, thus allowing for selective inhibition of lymphangiogenesis at lower dosages. Combined inhibition of integrin {alpha}5 and {alpha}v using inhibiting molecules did not significantly increase the anti-lymphangiogenic effect in vivo, thus suggesting an important functional role of integrin {alpha}5 in lymphangiogenesis. In summary, our findings demonstrate novel expression of specific integrins on growing lymphatic endothelial cells in vivo and reveal their functional role during lymphangiogenesis. This opens new treatment options for selective inhibition of lymphangiogenesis, eg, in oncology and transplant immunology.





This article has been cited by other articles:


Home page
J. Immunol.Home page
T. Dietrich, F. Bock, D. Yuen, D. Hos, B. O. Bachmann, G. Zahn, S. Wiegand, L. Chen, and C. Cursiefen
Cutting Edge: Lymphatic Vessels, Not Blood Vessels, Primarily Mediate Immune Rejections After Transplantation
J. Immunol., January 15, 2010; 184(2): 535 - 539.
[Abstract] [Full Text] [PDF]


Home page
Br J OphthalmolHome page
P Zimmermann, T Dietrich, F Bock, F K Horn, C Hofmann-Rummelt, F E Kruse, and C Cursiefen
Tumour-associated lymphangiogenesis in conjunctival malignant melanoma
Br J Ophthalmol, November 1, 2009; 93(11): 1529 - 1534.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T.-i. Kim, J. L. Chung, J. P. Hong, K. Min, K. Y. Seo, and E. K. Kim
Bevacizumab Application Delays Epithelial Healing in Rabbit Cornea
Invest. Ophthalmol. Vis. Sci., October 1, 2009; 50(10): 4653 - 4659.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
G. Zahn, D. Vossmeyer, R. Stragies, M. Wills, C. G. Wong, K. U. Loffler, A. P. Adamis, and J. Knolle
Preclinical Evaluation of the Novel Small-Molecule Integrin {alpha}5{beta}1 Inhibitor JSM6427 in Monkey and Rabbit Models of Choroidal Neovascularization
Arch Ophthalmol, October 1, 2009; 127(10): 1329 - 1335.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. Okazaki, A. Ni, O. A. Ayeni, P. Baluk, L.-C. Yao, D. Vossmeyer, G. Zischinsky, G. Zahn, J. Knolle, C. Christner, et al.
{alpha}5{beta}1 Integrin Blockade Inhibits Lymphangiogenesis in Airway Inflammation
Am. J. Pathol., June 1, 2009; 174(6): 2378 - 2387.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
E.-S. Chung, D. R. Saban, S. K. Chauhan, and R. Dana
Regulation of Blood Vessel versus Lymphatic Vessel Growth in the Cornea
Invest. Ophthalmol. Vis. Sci., April 1, 2009; 50(4): 1613 - 1618.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American Society for Investigative Pathology.